Compound ID | 2954
Class: Lipopolysaccharide synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Proteus mirabilis, Citrobacter koseri, Citrobacter freundii, Serratia marcescens, Morganella morganii, Yersinia spp., Shigella spp., Salmonella spp., Pseudomonas aeruginosa, and Acinetobacter baumannii; LpxC inhibitor |
| Description: | Synthetic compound; a morpholine-substituted biphenylacetylene molecule with difluoromethyl-l-allo-threonyl-hydroxamate head group; shows no tissue damage or effect to renal and hepatic function in plague infection in mice |
| Year first mentioned: | 2017 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/mbio.00674-17 |